1 |
van den Brule FA, Berchuck A, Bast RC, et al (1994). Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer, 30, 1096-9.
DOI
ScienceOn
|
2 |
Wan SY, Zhang TF, Ding Y (2011). Galectin-3 enhances proliferation and angiogenes of endothelial cells differentiated from bone marrow mesenchymal stem cells. Transplant Proc, 43, 3933-8.
DOI
ScienceOn
|
3 |
Wang Y, Nangia-Makker P, Balan V (2010). Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment. Cell Death Dis, 1, 101.
DOI
ScienceOn
|
4 |
Wani MC, Taylor HL, Wall ME, et al (1971). The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc, 93, 2325-7.
DOI
|
5 |
Weigel TL, Lotze MT, Kim PK, et al (2000). Paclitaxel-induced apoptosis in nonsmall cell lung cancer cell lines is associated with increased caspase-3 activity. J Thorac Cardiovasc Surg, 119, 795-803.
DOI
ScienceOn
|
6 |
Wongkham S, Junking M, Wongkham C, et al (2009). Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma. Cancer Sci, 100, 2077-84.
DOI
ScienceOn
|
7 |
Yan J, Katz A (2010). PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen Dependent and -Independent Prostate Cancer Cells. Integr Cancer Ther, 9, 197-203.
DOI
ScienceOn
|
8 |
Zhao Q, Barclay M, Hilkens J, et al (2010). Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Molecular Cancer, 9, 154.
DOI
ScienceOn
|
9 |
Zhu X, Ohtsubo M, Bohmer RM, et al (1996). Adhesiondependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol, 133, 391-403.
DOI
ScienceOn
|
10 |
Ahn HJ, Kim YS, Kim JU, et al (2004). Mechanism of taxolinduced apoptosis in human SKOV3 ovarian carcinoma cells. J Cell Biochem, 91, 1043-52.
DOI
ScienceOn
|
11 |
Bae J, Lim MC, Choi JH, et al (2009). Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol Oncol, 20, 101-6.
DOI
ScienceOn
|
12 |
Banerjee S, Gore M (2009). The future of targeted therapies in ovarian cancer. Oncologist, 14, 706-16.
DOI
ScienceOn
|
13 |
Loeffler M, Daugas E, Susin SA, et al (2001). Dominant cell death induction by extramitochondrially targeted apoptosisinducing factor. FASEB J, 215, 758-67.
|
14 |
Bankowski E, Sobolewski K, Romanowicz L, et al (1996). Collagen and glycosaminoglycans of Wharton's jelly and their alterations in EPH-gestosis. Eur J Obstet Gynecol Reprod Biol, 66, 109-17.
DOI
ScienceOn
|
15 |
Choi JH, Chun KH, Raz A, et al (2004). Inhibition of N-(4-hydroxyphenyl) retinamide-induced apoptosis in breast cancer cells by galectin-3. Cancer Biol Ther, 3, 447-52.
DOI
|
16 |
Chumworathayi B (2013). Personalized cancer treatment for ovarian cancer. Asian Pac J Cancer Prev, 14, 1661-4.
과학기술학회마을
DOI
ScienceOn
|
17 |
Elola MT, Wolfenstein-Todel C, Troncoso MF, et al (2007). Galectins: matricellular glycan-binding proteins linking celladhesion, migration, and survival. Cell Mol Life Sci, 64, 1679-700.
DOI
|
18 |
Glinsky VV, Kiriakova G, Glinskii OV, et al (2009). Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo. Neoplasia, 11, 901-9.
DOI
|
19 |
Goncalves A, Braguer D, Carles G, et al (2000). Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4). Biochem Pharmacol, 60, 1579-84.
DOI
ScienceOn
|
20 |
Inohara H, Raz A (1994). Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J, 11, 527-32.
DOI
ScienceOn
|
21 |
Inohara H, Akahani S, Raz A (1998). Galectin-3 stimulates cell proliferation. Exp Cell Res, 245, 294-302.
DOI
ScienceOn
|
22 |
Kim MK, Sung CO, Do IG, et al (2011). Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma. Int J Clin Oncol, 16, 352-8.
DOI
|
23 |
Iurisci I, Tinari N, Natoli C, et al (2000). Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res, 6, 1389-93.
|
24 |
Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics. CA Cancer J Clin, 56, 106-30.
DOI
ScienceOn
|
25 |
Kim HR, Lin HM, Biliran H, et al (1999). Cell cycle arrest and inhibition of anoikis by Galectin-3 in human breast epithelial cells. Cancer Res, 59, 4148-54.
|
26 |
Kiwaki K, Novak CM, Hsu DK (2007). Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. Obesity, 15, 32-9.
DOI
|
27 |
Kuwabara I, Liu FT (1996). Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol, 156, 3939-44.
|
28 |
Lee JW, Juliano R (2004). Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells, 17, 188-202.
|
29 |
Lin HM, Pestell RG, Raz A, et al (2002). Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMPresponsive element in human breast epithelial cells. Oncogene, 21, 8001-10.
DOI
ScienceOn
|
30 |
Nangia-Makker P, Nakahara S, Hogan V, et al (2007). Galectin-3 in apoptosis, a novel therapeutic target. J Bioenerg Biomembr, 39, 79-84.
DOI
|
31 |
Ochieng J, Leite-Browning ML, Warfield P (1998). Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun, 246, 788-91.
DOI
ScienceOn
|
32 |
Pienta KJ, Naik H, Akhtar A, et al (1995). Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst, 87, 348-53.
DOI
ScienceOn
|
33 |
O'Driscoll L, Linehan R, Liang YH, et al (2002). Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. Anticancer Res, 22, 3117-25.
|
34 |
Oka N, Nakahara S, Takenaka Y, Fukumori T, et al (2005). Galectin-3 inhibits tumor necrosis factor-related apoptosisinducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells. Cancer Res, 65, 7546-53.
DOI
|
35 |
Perkins C, Kim CN, Fang G, et al (1998). Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res, 8, 4561-6.
|
36 |
Platt D, Raz A (1992). Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst, 84, 438-42.
DOI
|
37 |
Sher I, Adham SA, Petrik J, et al (2009). Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis. Int J Cancer, 124, 553-61.
DOI
ScienceOn
|
38 |
Streetly MJ, Maharaj L, Joel S, et al (2010). GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death. Blood, 115, 3939-48.
DOI
ScienceOn
|
39 |
Tehranian N, Sepehri H, Mehdipour P, et al (2012). Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and LNCaP prostate cancer cell lines. Cell Biol Int, 36, 601-10.
DOI
ScienceOn
|